Skip to Content


In the US, Tresiba (insulin degludec systemic) is a member of the drug class insulin and is used to treat Diabetes Mellitus, Diabetes - Type 1 and Diabetes - Type 2.

US matches:

UK matches:

Ingredient matches for Tresiba

Insulin Degludec

Insulin Degludec is reported as an ingredient of Tresiba in the following countries:

  • Austria
  • Bosnia & Herzegowina
  • Denmark
  • Finland
  • Greece
  • Italy
  • Japan
  • Lebanon
  • Mexico
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russian Federation
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom
  • United States

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.